6.4(top 5%)
impact factor
17.8K(top 1%)
papers
1.0M(top 1%)
citations
327(top 1%)
h-index
6.8(top 5%)
extended IF
21.9K
all documents
1.1M
doc citations
478(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040Ophthalmology20144,878
2Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050Ophthalmology20162,988
3Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology20032,779
4Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs—An Extension of the Modified Airlie House ClassificationOphthalmology19912,238
5Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology20122,021
6Prevalence of Age-related MaculopathyOphthalmology19921,712
7Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular DegenerationOphthalmology20121,585
8Ranibizumab for Diabetic Macular EdemaOphthalmology20121,426
9Early Photocoagulation for Diabetic RetinopathyOphthalmology19911,344
10Clinical Classification of Age-related Macular DegenerationOphthalmology20131,308
11Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology20101,303
12Imaging of Macular Diseases with Optical Coherence TomographyOphthalmology19951,235
13The RESTORE StudyOphthalmology20111,230
14Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR StudyOphthalmology20091,204
15Predictors of Long-term Progression in the Early Manifest Glaucoma TrialOphthalmology20071,202
16Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular DegenerationOphthalmology20061,155
17Photocoagulation Treatment of Proliferative Diabetic RetinopathyOphthalmology19811,114
18Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the atherosclerosis risk in communities study11The authors have no proprietary interest in the equipment and techniques described in this article.Ophthalmology19991,092
19Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgeryOphthalmology20011,083
20The Wisconsin Age-related Maculopathy Grading SystemOphthalmology19911,078
21Prevalence of Age-related Maculopathy in AustraliaOphthalmology19951,000
22Uveal Melanoma: Trends in Incidence, Treatment, and SurvivalOphthalmology2011999
23Limbal Autograft Transplantation for Ocular Surface DisordersOphthalmology1989996
24Survey of 1264 patients with orbital tumors and simulating lesionsOphthalmology2004995
25Intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology2002993
26Outdoor Activity Reduces the Prevalence of Myopia in ChildrenOphthalmology2008980
27Survey of 520 Eyes with Uveal MetastasesOphthalmology1997975
28Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein OcclusionOphthalmology2010950
29Risk factors for age-related macular degenerationOphthalmology2001942
30Automated Identification of Diabetic Retinopathy Using Deep LearningOphthalmology2017936
31Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular EdemaOphthalmology2014930
32Ranibizumab for Macular Edema following Central Retinal Vein OcclusionOphthalmology2010924
33Prevalence of GlaucomaOphthalmology1992903
34The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular HoleOphthalmology2013900
35Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology2016896
36The Five-year Incidence and Progression of Age-related MaculopathyOphthalmology1997894
37The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and AustraliaOphthalmology2010889
38Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZONOphthalmology2013887
39Prevalence of Open-angle Glaucoma in AustraliaOphthalmology1996873
40Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045Ophthalmology2021867
41The relationship between glaucoma and myopiaOphthalmology1999841
42Fundus Photographic Risk Factors for Progression of Diabetic RetinopathyOphthalmology1991834
43Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease11Reprint requests to: Linda Lewis, 575 Anton Blvd, Suite 900, Costa Mesa, CA 92626.Ophthalmology2000808
44Risk factors associated with age-related macular degenerationOphthalmology2000803
45Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus SurgeryOphthalmology1980802
46Ranibizumab for Macular Edema following Branch Retinal Vein OcclusionOphthalmology2010789
47Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaOphthalmology2016764
48Visual Acuity and the Causes of Visual Loss in AustraliaOphthalmology1996761
49Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis StudyOphthalmology2004742
50The Wisconsin Epidemiologic Study of Diabetic RetinopathyOphthalmology1984740